NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CytRx Corporation 

11726 San Vicente Blvd., Suite 650

Los Angeles  California  90049  U.S.A.
Phone: 310-826-5648 Fax: 310-826-6139


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
CytRx Corporation (CYTR) to Initiate Phase 2 Clinical Trial with INNO-206 in Patients with Advanced Gastric Cancer 11/18/2009 9:00:35 AM    More...
CytRx Corporation (CYTR) Reports 2009 Third Quarter Financial Results 11/9/2009 9:51:38 AM    More...
CytRx Corporation (CYTR) Announces Publication of Paper Stating that Chaperone Amplification Represents a ‘Significant Strategy’ in Anti-aging Pharmaceutical Design 10/28/2009 8:59:46 AM    More...
CytRx Corporation (CYTR) Fortifies Executive Suite with Addition of Chief Medical Officer 10/13/2009 8:56:22 AM    More...
CytRx Corporation (CYTR) and Cephalon, Inc. (CEPH) Oncology Therapies to be Evaluated as Treatment for Relapsed Acute Promyelocytic Leukemia 9/14/2009 9:34:13 AM    More...
CytRx Corporation (CYTR) Secures Key European Patent for Arimoclomol 9/10/2009 9:41:31 AM    More...
CytRx Corporation (CYTR) to Present at the Sachs Associates Annual Biotech in Europe Investor Forum 9/9/2009 9:19:21 AM    More...
CytRx Corporation (CYTR) Receives FDA Letter Regarding Arimoclomol Phase IIb Clinical Trial for ALS 9/8/2009 9:06:12 AM    More...
CytRx Corporation (CYTR)'s Arimoclomol Demonstrates Statistically Significant Cellular Evidence of Both Neuroprotection and Neuroregeneration in Animal Stroke Study 8/24/2009 9:13:00 AM    More...
CytRx Corporation (CYTR)'s Drug Candidate INNO-206 Produces Statistically Significant Tumor Shrinkage in Animal Model of Small Cell Lung Cancer 8/12/2009 8:30:41 AM    More...
12345678910...